The New York Times – Business:
The company will study its vaccine in children ages six months through 11 in the United States and Canada.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.
The New York Times – Business:
The company will study its vaccine in children ages six months through 11 in the United States and Canada.
This post first appeared in The New York Times – Business. Read the original article.